M.J. Millward
Cancer Therapeutics Research Group
Sydney Cancer Centre
Sydney
Australia
[email]@canc.rpa.cs.nsw.gov.au
Name/email consistency: low
- Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Millward, M.J., Boyer, M.J., Lehnert, M., Clarke, S., Rischin, D., Goh, B.C., Wong, J., McNeil, E., Bishop, J.F. Ann. Oncol. (2003)
- Phase I trial of cremophor EL with bolus doxorubicin. Millward, M.J., Webster, L.K., Rischin, D., Stokes, K.H., Toner, G.C., Bishop, J.F., Olver, I.N., Linahan, B.M., Linsenmeyer, M.E., Woodcock, D.M. Clin. Cancer Res. (1998)